✦ LIBER ✦

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

✍ Scribed by Pierre D Delmas; Francoise Munoz; Dennis M Black; Felicia Cosman; Steven Boonen; Nelson B Watts; David Kendler; Erik F Eriksen; Peter G Mesenbrink; Richard Eastell

Book ID: 111485739
Publisher: American Society for Bone and Mineral Research
Year: 2009
Tongue: English
Weight: 653 KB
Volume: 24
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.090310

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of once-yearly zoledronic acid 5

Effects of once-yearly zoledronic acid 5 mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis

✍ F. Cosman⁎; E.F. Eriksen; C. Recknor; P. Miller; S.L. Greenspan; P. Papanastasio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Poster 150: Effect of Once-Yearly Infusi

Poster 150: Effect of Once-Yearly Infusion of 5mg of Zoledronic Acid in Postmenopausal Women With Osteoporosis: The HORIZON-Pivotal Fracture Trial

✍ Meryl S. LeBoff; Dennis Black; Pierre Delmas; Richard Eastell; Ian Reid; Steve C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The Effect of Denosumab on Bone Turnover

The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis

✍ Steven Cummings; Andrea Wang; Javier San Martin; Mike McClung; Christiansen Clau 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Efficacy and Safety of a Once-Yearly Int

Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

✍ Steven Boonen; Dennis M. Black; Cathleen S. Colón-Emeric; Richard Eastell; Jay S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Relationship of changes in total hip bon

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

✍ Richard M Jacques; Steven Boonen; Felicia Cosman; Ian R Reid; Douglas C Bauer; D 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB

Effects of alendronate and risedronate o

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis

✍ Aysegul Atmaca; Olcay Gedik 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 279 KB